M. David Rudd, PhD, ABPP, is a Distinguished University Professor of Psychology and Director of the Rudd Institute for Veteran and Military Suicide Prevention and past president at the University of Memphis. The entirety of his clinical and scientific career has focused on the assessment, clinical management, and treatment of suicidality across the full range of clinical settings. He has served as PI, Co-PI, or Co-I on multiple NIH and DoD funded grants. He has also conducted several randomized clinical trials (RCT), all with successful outcomes. Namely, the first RCT for BCBT conducted at Fort Carson that demonstrated a 60% reduction of post-treatment suicide attempts relative to treatment as usual, and recent work with Dr. Gretchen Diefenbach and Dr. David Tolin of Yale on an RCT modifying BCBT for an inpatient setting that resulted in a 60% reduction of relative risk for suicide attempt in comparison to treatment as usual, a 71% reduction in hospital readmission rates, and 75% reduction in emergency department visits.